Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine M72/AS01E in Participants With Well-controlled HIV
Clinical trial NCT04556981 · COMPLETED
Trial details
- NCT number
- NCT04556981
- Sponsor
- Gates Medical Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-17
- Primary completion
- 2022-08-12
- Enrollment
- 402
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.